EMERYVILLE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: XOMA), the biotech royalty aggregator, announced today ...

Analysts have recently evaluated XOMA Royalty and provided 12-month price targets. The average target is $119.2, accompanied ...

Q1 2025 Earnings Call Transcript February 3, 2025 Operator: Good day. Thank you for standing by. Welcome to Twist ...

I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision ...